Skip to main content
. 2019 Jul 25;42(3):155–165. doi: 10.1016/j.bj.2019.02.003

Fig. 1.

Fig. 1

Neoadjuvant treatment of a breast cancer patient with propranolol. (A) Immunohistochemical staining of breast cancer tissue from the patient discussed in this study for β1-AR, β2-AR, and β3-AR proteins. Purple/brown staining indicated positivity for the antigen tested. (B) Flow diagram showing the treatment and tumor tissue collection schemes for the stage III breast cancer patient.